{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2418, 
        2425
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2426, 
        2435
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2509, 
        2518
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2225, 
        2248
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2630, 
        2650
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2319, 
        2346
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2359, 
        2363
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2451, 
        2455
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2585, 
        2589
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2604, 
        2608
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        1481, 
        1510
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2521, 
        2547
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2409, 
        2417
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2498, 
        2508
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2351, 
        2357
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2552, 
        2558
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2365, 
        2369
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2590, 
        2594
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2348, 
        2349
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2436, 
        2437
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2549, 
        2551
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 4^9999^MOH|PIMS|CCO|20160503000242|3D954690D0B41615E21B31B25BACEC86E49E72F8|ORU^R01|1605030002414981|P|2.5|||\nPID|1||999999^^^^CMR^HOSPITAL 4&9999&MOH~999999^^^^MRN^HOSPITAL 4&9999&MOH~9999999999&TV&^^^^JHN||XXXXXXX^XXXXX^^^^||99999999|F|^^^^^||99 XXXXXXXXXX XXXXXXXX X99^^XXXXX XXXX^^X9X9X9^999||9999999999||||||||^^|||||||||N|||\nOBR|1||S16-7096|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||201604271040|||90707^XXXXX^XXXX^XXXXXXXX^^^||||201604280839||^^^^^^||||N||201605021449|||F|||^TASHAROFI KIA^MINA^ ||||99999^XXXXXXXXX^XXXXXX^X^^^|||||\n\n\n\n\n\n\n\nPath Report.addendum spec\n\nINTERPRETATION:\nBlock 1A from the tumor in the above patient was examined for estrogen and progesterone receptors with the following results:\n           \tResults \t\t% of Positive\tAverage Intensity\n           \t    \t\tCells\nEstrogen Receptor  \tPositive\t\t100      \tStrong\nProgesterone Receptor\tPositive\t\t70      \tModerate to strong\nInternal Control Appropriately Immunoreactive:\tYes\nExternal Control Appropriately Immunoreactive:\tYes\nAppropriate formalin fixation time achieved: \tYes\nAntibody clone 6FII used for estrogen receptor. Antibody clone PR16 used for progesterone receptor.\nA positive result refers to 1% or more of the tumor cell nuclei showing positive staining. Staining intensity is recorded as weak, moderate or strong based on the average staining on the entire tissue section relative to the intensity of positive controls run with the same batch.\n\n\nPath report.gross description\n\n1. The specimen is received in formalin in a container labelled with the patient's demographic details and as \"Ultrasound Core Biopsy Left Breast 1 O'clock N+2-4\". It consists of 4 cores of soft white-tan tissue measuring from 0.6 cm to 1.7 cm in length and up to 0.2 cm in diameter.\nSections: A, B - 4/2 EIT\nCold Ischemic Time:0:00Total Fixation Time:29:20\n2. The specimen is received in formalin in a container labelled with the patient's demographic details and as \"Ultrasound Core Biopsy Left Axilla \". It consists of 4 cores of soft white-tan tissue measuring from 0.5 cm to 0.8 cm in length and up to less than 0.1 cm in diameter.\nSections: A, B - 4/2 EIT\nCold Ischemic Time:0:00Total Fixation Time:29:15\n\n\nPath report.relevant Hx\n\nLeft breast malignant, left axilla indeterminate. Prior biopsy ALH\n\n\nPath report.final diagnosis\n\n1. Breast (left, 1:00 N+2), ultrasound-guided core biopsy:\n- INVASIVE LOBULAR CARCINOMA\n2. Lymph node (left axilla), ultrasound-guided core biopsy:\n- METASTATIC CARCINOMA\n\n\nPath report.site of origin\n\n1: Breast Ultrasound Guided Biopsy, Left 1:00 N+2-4\n2: Left Axilla Core Biopsy\n\n\nPath report.comments\n\nThe tumour in biopsy #1 is negative for E-cadherin, consistent with lobular phenotype.\nER, PR and HER2/neu studies will be performed on biopsy #1 and the results will be reported separately.\n\n\n"
}